Zinzino AB announced its preliminary sales results for the month of January 2026. Revenue during the month for Zinzino’s markets grew by 20%, totaling $30 million. The Faun Pharma external sales segment also experienced growth, totaling $786,000. Overall, group revenue reached $31 million.
South America, which includes Peru and Colombia, saw the strongest growth (344%). North America, which includes Canada, US and Mexico, grew by 94%. All other markets, with the exception of East Europe (Czech Republic, Slovakia, Hungary, Poland, Romania) saw positive growth rates.
